Ok so neu has made it very clear that tox studies and commercialisation work needs to be done prior to p3 starting and I’d say u can pretty much guarantee that’s where r/d money is going
If they were going alone in p3, which I put at the same chance as lopez’s 6c CR (for a number of reasons) the ramp up costs in preparation for that would be much higher than 1.8 mill
Anyway u lot keep jumping at shadows it’s keeping me entertained while mgmt put a bow on this
Ann: Appendix 4C - quarterly, page-23
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.63 |
Change
-1.080(6.46%) |
Mkt cap ! $1.997B | |||
| Open | High | Low | Value | Volume |
| $16.61 | $16.65 | $15.54 | $8.354M | 529.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 830 | $15.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.74 | 1484 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |